首页> 外国专利> FORMULATIONS FOR ENHANCED BIOAVAILABILITY OF ORALLY ADMINISTERED POLAR AGENTS

FORMULATIONS FOR ENHANCED BIOAVAILABILITY OF ORALLY ADMINISTERED POLAR AGENTS

机译:用于增强口服给药极性剂的生物利用度的制剂

摘要

A composition is described having improved oral permeability of polar agents such as neuraminidase inhibitors. The composition includes one or more polar agents and one or more permeability enhancers such that the composition increases the amount of the polar agent capable of being transported across a Caco-2 cell membrane by at least 150% relative to the amount capable of being transported across the Caco-2 Cell membrane in the absence of the permeability enhancer. Oral dosage forms including the composition, and methods of treating or preventing influenza infection are also provided.
机译:描述了一种具有改善极性剂的口服渗透性如神经氨酸酶抑制剂的组合物。 该组合物包括一种或多种极性药剂和一种或多种渗透性增强剂,使得组合物增加能够在CaCO-2细胞膜上通过相对于能够被运输的量的量而在CaCo-2细胞膜上运输的极性剂的量 在没有渗透性增强剂的情况下,Caco-2细胞膜。 还提供了包括组合物的口服剂型和治疗或预防流感感染的方法。

著录项

  • 公开/公告号EP3320921B1

    专利类型

  • 公开/公告日2022-01-05

    原文格式PDF

  • 申请/专利权人 ALA WAI PHARMA INC.;

    申请/专利号EP20170192947

  • 发明设计人 HOLMES ERIC;HITE MICHAEL;

    申请日2008-11-05

  • 分类号A61K47/10;A61K47/14;A61K9/48;A61K47/18;

  • 国家 EP

  • 入库时间 2022-08-24 23:14:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号